Birkenstock Holding plc (BIRK) Stock Price & How to Invest

Birkenstock makes the cork-and-latex footbed sandals and clogs it has been producing since 1774, sold under silhouette names most buyers know better than the ticker: Arizona, Gizeh, Madrid, and the Boston clog that has become the growth engine. Roughly 100% of footwear units are produced in the company's own German factories (Görlitz, St. Katharinen, Bernstadt and Pasewalk), which is unusual in footwear and is the reason gross margin sits in the mid-50s rather than the low 40s. The company sells through three reported regions, Americas, EMEA and APAC, split across a direct-to-consumer channel (own stores and birkenstock.com) and a deliberately rationed B2B wholesale channel. Adjacent lines include Papillio, Birkenstock Natural Skin Care and sleep systems, plus collaborations with Dior, Manolo Blahnik, Stüssy and Ganni that anchor the brand at a higher price point than the $110 Arizona.

The investment picture in August 2026 is a growth story with a currency and tariff wrapper around it. Fiscal 2026 second quarter revenue was ~€618 million, up ~14% in constant currency but only ~8% as reported, and net profit fell ~22% to ~€82 million because of FX translation, incremental US tariffs on European-made footwear and channel mix. Management confirmed the full-year target of ~13% to 15% constant-currency growth and a ~30.0% to 30.5% adjusted EBITDA margin, so the top line is intact while the reported earnings line absorbs the friction. At a market cap of roughly $7.1 billion the stock trades near the high-teens on trailing earnings, well below the multiple it carried at IPO, with L Catterton and Financière Agache still holding a controlling stake. Fiscal third quarter results (quarter ended June 30, 2026) are scheduled for August 13, 2026, which is the next real test of whether the constant-currency line holds.

Currency is the single largest gap between the operating result and the reported one: the company reports in euros, so dollar weakness turns ~14% constant-currency growth into ~8% reported growth and cut net profit ~22% in the fiscal second quarter. US tariffs on EU-made footwear are a stated ~100 basis point gross-margin headwind in the fiscal third quarter and ~50 basis points in the fourth, and because production cannot be shifted out of Germany without breaking the Made in Germany positioning, there is no easy sourcing workaround. This is a single-brand company with no diversification if sandal and clog demand cools, and the Boston clog specifically is now the growth driver that a fashion cycle could turn against. Cheap lookalikes from Skechers, Amazon sellers and private-label retailers compete directly on the footbed silhouette at a third of the price. L Catterton and Financière Agache retain control, so minority holders have limited influence and any secondary sale is a supply overhang; the Middle East conflict alone reduced EMEA revenue by roughly €6 million in the fiscal second quarter, showing how exposed the wholesale footprint is to regional disruption.

21 analysts publish price targets on BIRK, averaging $52.96 against a $38.45 price as of August 2026, or +37.7%. The published targets run from $40.48 to $76.19, a moderate spread, and the ratings split 17 buy, 5 hold, 0 sell. Over the last six months there has been 1 raise and 6 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full BIRK forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Birkenstock Holding plc. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Closed-toe silhouettes extend the selling season. The Boston clog and the shearling-lined variants turned a spring and summer sandal brand into something that sells in December, which is why fiscal first quarter revenue grew ~18% in constant currency on holiday demand. The most optimistic published target, $76.19, assumes this works close to its best case.

The case against. Currency is the single largest gap between the operating result and the reported one: the company reports in euros, so dollar weakness turns ~14% constant-currency growth into ~8% reported growth and cut net profit ~22% in the fiscal second quarter. The most pessimistic target, $40.48, is roughly what BIRK is worth if this bites instead.

Read the full bull and bear case on BIRK, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Birkenstock Holding plc's investor relations page or your broker.

• Revenue (TTM): ~€2.2 billion (reports in euros; fiscal year ends September 30)
• Fiscal 2026 revenue target: ~€2.30 billion to €2.35 billion reported, ~13% to 15% constant-currency growth
• Q2 FY2026 revenue (quarter ended March 31, 2026): ~€618 million, up ~14% in constant currency and ~8% as reported
• Q2 FY2026 adjusted EBITDA: ~€198 million, a ~32.1% margin; full-year target ~30.0% to 30.5%
• Q2 FY2026 net profit: ~€82 million, down ~22% year over year on FX, US tariffs and mix
• Market cap: ~$7.1 billion, roughly ~18x trailing earnings as of late July 2026

Fiscal 2025 closed at ~€2.1 billion of revenue, up ~16% reported and ~18% in constant currency, with ~€667 million of adjusted EBITDA at a ~31.8% margin. Fiscal 2026 has kept the constant-currency pace while adjusted gross margin fell ~310 basis points in the second quarter to ~54.6%, split between currency translation, incremental tariffs and a heavier wholesale mix. The gap between the ~13% to 15% constant-currency target and the ~10% to 12% reported target is the euro-dollar arithmetic, not a demand change.

Other names that sit close to BIRK: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get BIRK exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so BIRK sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where BIRK fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

BIRK is a rare case of a heritage brand compounding volume, price and geography at once, with the euro reporting currency and US tariff line deciding how much of that reaches the reported result.

Whether BIRK is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is BIRK a buy or a sell?, and where the stock could go from here in the BIRK stock forecast.

For income investors, whether BIRK pays a dividend and how the payout looks is covered in does BIRK pay a dividend? And to weigh BIRK against a peer, read the full side-by-side comparisons: BIRK vs CROX and BIRK vs DECK.